-
Mashup Score: 8
Patients in the ponsegromab group had significantly greater weight gain and physical activity than those in the placebo arm in a phase 2 trial.
Source: www.cancernetwork.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Cancer’s New Face: Younger and Female - 1 month(s) ago
Although long considered a disease of aging, certain cancers are turning up more often in younger women, according to a new report.
Source: www.nytimes.comCategories: General Medicine News, Hem/OncsTweet-
https://t.co/gxC3JSR55y
-
-
Mashup Score: 4Make it your resolution to attend HOPE Summit in 2025 - LUNGevity Foundation - OncoDaily - 2 month(s) ago
Make it your resolution to attend HOPE Summit in 2025 – LUNGevity Foundation / cancer, HOPE Summit 2025, LUNGevity Foundation, OncoDaily, Oncology
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Make it your resolution to attend HOPE Summit in 2025 - @LUNGevity https://t.co/YMjkZmBJyF #Cancer #HOPESummit25 #LCSM #Me…
-
-
Mashup Score: 2Los Angeles Against the Mountains - 2 month(s) ago
John McPhee’s 1988 report about life in the San Gabriel Mountains, in northern Los Angeles County, which were disintegrating into rock porridge at a rate that was among the fastest in the world.
Source: www.newyorker.comCategories: General Medicine News, Hem/OncsTweet-
The devastating fires in SoCal remind me of reading John McPhee's "The Control of Nature" in college. It includes this essay from 1988, "Los Angeles Against the Mountains," telling the cyclical battle of fires and mudslides fueled by the Santa Ana winds https://t.co/ERdyKObljO
-
-
Mashup Score: 7
We are pleased to announce that the VOICE course will once again be residential and held at Barts Cancer Centre from the 31st August to 5th September 2025. Please email if you would like to register an interest or for more information. Members of ICPV are actively involved in many areas of research. To facilitate and enhance our role in these activities, members aim to understand the fundamentals of cancer, study design and current areas of controversy and research. Much of this is gained through
Categories: General Medicine News, Hem/OncsTweet-
This is a great opportunity for patient advocates who want to learn more about #science and #research. I know Dave Chuter, who helps run it, through our respective roles as advocates with @CancerGrand. https://t.co/aKI1u8LgXv
-
-
Mashup Score: 1
Amy Moore: PD-1/VEGF combos are a strategy to watch in lung cancer / Amy Moore, cancer, Immune Checkpoint Inhibitors, Keiju Aokage, Lung cancer, Masahiro
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @OncoDailyIO: PD-1/VEGF combos are a strategy to watch in lung cancer - @acmoorephd @CCR_AACR https://t.co/VJLqjwpYdT #Cancer #LCSM…
-
-
Mashup Score: 29Design of a Fc-engineered tetravalent bispecific antibody targeting PD-1 and VEGF with cooperative biological effects - 2 month(s) ago
Clinical studies have shown that combination therapy of PD-1 and VEGF antibodies significantly improves clinical benefit over PD-1 antibody alone in certain settings. Ivonescimab, an on-market tetravalent anti-PD-1/VEGF bispecific antibody, was designed to improve efficacy and safety over combo therapy. In this study, the mechanism of action is investigated. In the presence of VEGF, ivonescimab forms soluble complexes with VEGF dimers, leading to the enhanced binding avidity of ivonescimab to PD-1 therefore promoting its increased potency on PD-1/PD-L1-signaling blockade.
Source: www.cell.comCategories: General Medicine News, Hem/OncsTweet-
Ivonescimab is a bispecific Ab targeting both PD1 and VEGF, enhancing binding to both while the linker portion is designed to minimize side effects. It is currently being evaluated against #NSCLC, #CRC, #TNBC. https://t.co/Af2KXfoVJU
-
-
Mashup Score: 1
The advisory “highlights alcohol use as a leading preventable cause of cancer in the United States, contributing to nearly 100,000 cancer cases and about 20,000 cancer deaths each year.”
Source: www.cnn.comCategories: General Medicine News, Hem/OncsTweet-
https://t.co/u8l3zxcYhl
-
-
Mashup Score: 17International Lung Cancer Survivorship Conference (ILCSC) - 2 month(s) ago
The International Lung Cancer Survivorship Conference (ILCSC) is a free virtual educational conference designed for people with lung cancer, caregivers, and advocates. This conference offers you a unique opportunity to engage with top researchers and hear about the latest advancements in treatment…
Source: reg.eventmobi.comCategories: General Medicine News, Hem/OncsTweet-
This year's @LUNGevity International Lung Cancer Survivorship Conference (#ILCSC24) will include a dedicated session for Indian patients, facilitated by Dr. @deeptibehl1 and our own Dr. Upal Basu Roy. Registration is FREE and OPEN for this virtual event! https://t.co/E942WxbjMJ https://t.co/dpHzXrL7bd
-
-
Mashup Score: 12
The tumor microenvironment (TME) is a complex, highly structured, and dynamic ecosystem that plays a pivotal role in the progression of both primary and metastatic tumors. Precise assessment of the dynamic spatiotemporal features of the TME is crucial for understanding cancer evolution and designing effective therapeutic strategies. Cancer is increasingly recognized as a systemic disease, influenced not only by the TME, but also by a multitude of systemic factors, including whole-body metabolism, gut microbiome, endocrine signaling, and circadian rhythm. In this review, we summarize the intrinsic, extrinsic, and systemic factors contributing to the formation of ‘cold’ tumors within the framework of the cancer-immunity cycle. Correspondingly, we discuss potential strategies for converting ‘cold’ tumors into ‘hot’ ones to enhance therapeutic efficacy.
Source: www.cell.comCategories: General Medicine News, Hem/OncsTweet-
RT @AndresFCardonaZ: Turning cold into hot: emerging strategies to fire up the tumor microenvironment https://t.co/EstO8RzsgP
-
This study is an important advance forward for patients impacted by #cancer #cachexia Ponsegromab Reduces Symptoms Linked to Cancer Cachexia, Elevated GDF-15 https://t.co/AnefsIozf9 via @@CancerNetwrk